The store will not work correctly when cookies are disabled.
1-ethyl-7-(naphthalen-1-yloxy)-1,3-dihydro-2H-benzo[d]imidazol-2-one
ID: ALA4519998
PubChem CID: 145999190
Max Phase: Preclinical
Molecular Formula: C19H16N2O2
Molecular Weight: 304.35
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CCn1c(=O)[nH]c2cccc(Oc3cccc4ccccc34)c21
Standard InChI: InChI=1S/C19H16N2O2/c1-2-21-18-15(20-19(21)22)10-6-12-17(18)23-16-11-5-8-13-7-3-4-9-14(13)16/h3-12H,2H2,1H3,(H,20,22)
Standard InChI Key: SAWNOVYQJFNEAZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 26 0 0 0 0 0 0 0 0999 V2000
42.8887 -11.6222 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.8876 -12.4418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.5956 -12.8507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.5939 -11.2134 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.3025 -11.6186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.3073 -12.4373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.0873 -12.6857 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
45.5647 -12.0206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.0795 -11.3612 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
46.3818 -12.0158 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
43.5914 -10.3962 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
42.8825 -9.9897 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.4678 -9.1776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.4729 -9.9990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.1816 -10.4017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.3275 -10.5825 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
46.1258 -10.4079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.1753 -8.7669 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.8812 -9.1766 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.5869 -8.7703 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.5879 -7.9543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.8774 -7.5464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.1746 -7.9551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 5 1 0
8 10 2 0
4 11 1 0
11 12 1 0
12 19 2 0
18 13 2 0
13 14 1 0
14 15 2 0
15 12 1 0
9 16 1 0
16 17 1 0
18 19 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 304.35 | Molecular Weight (Monoisotopic): 304.1212 | AlogP: 4.30 | #Rotatable Bonds: 3 |
Polar Surface Area: 47.02 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.73 | CX Basic pKa: ┄ | CX LogP: 4.04 | CX LogD: 4.04 |
Aromatic Rings: 4 | Heavy Atoms: 23 | QED Weighted: 0.61 | Np Likeness Score: -0.57 |
References
1. Pribut N, Basson AE, van Otterlo WAL, Liotta DC, Pelly SC.. (2019) Aryl Substituted Benzimidazolones as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors., 10 (2): [PMID:30783503] [10.1021/acsmedchemlett.8b00549] |